Headaches Headaches with retatrutide are usually mild and occur as the body adapts to changes in metabolism and appetite regulation
It contributes to blood glucose control by stimulating glucose-dependent insulin secretion, inhibiting glucagon release, delaying gastric emptying, and reducing appetite
GLP-1 is an incretin hormone that enhances glucose-dependent insulin secretion and suppresses glucagon release from the pancreas
Dual and Triple Incretin-Based Co-agonists: Novel Therapeutics for Obesity and Diabetes
Commonly reported issues include: Gastrointestinal Distress: Nausea, vomiting, and diarrhea are common, particularly when starting the medication
Saratoga Springs, Utah County and surrounding areas Statewide Utah, Arizona & Idaho The Next Generation Heard about retatrutide